Replies to post #7858 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

The molecular diagnostics is a subsidiary of Abbott Laboratories and deals in genetic testing.

This is going to need more clarification before you can actually state who will end up with RECAF.

To pay 8.13 billion, you should get a sizable portion of the testing that is currently done. The release also stated that GE would be in a better positon of dealing with automated testing. Since RECAF is not a genetic test, I think it may be going to GE.